JBIO FY 2023 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$96,000

Operating Income

-$81M

Net Income

-$76M

EPS (Diluted)

$-100.38

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$127M

Total Liabilities

$18M

Stockholders' Equity

$109M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$96,000	-$68,000	-41.2%
Operating Income	-$81M	-$53M	-52.9%
Net Income	-$76M	-$52M	-46.6%